News

Goldman Sachs Projects 24% Growth Potential for Mattel Stock

Goldman Sachs Projects 24% Growth Potential for Mattel Stock

Goldman Sachs Maintains Strong Outlook for Mattel Inc.

Goldman Sachs has reaffirmed its strong Buy rating on Mattel Inc. (NASDAQ: MAT). The company reported mixed results for the third quarter of 2024 and continues to navigate a challenging market landscape. Despite the volatility, Goldman Sachs has a positive price target of $22.00, signaling a potential upside of 24% from the current levels.

Third Quarter Results Show Mixed Performance

Mattel recently announced its third-quarter financial results, revealing a revenue figure of $1.844 billion, which reflects a 4% decline year-over-year. This figure fell short of analysts' expectations of $1.860 billion. However, in a positive twist, the company reported an Adjusted EBITDA of $584 million, surpassing the projected $521 million, alongside an Adjusted EPS of $1.14, outpacing the consensus estimate of $0.94.

Changes in Full-Year Guidance

Following the third-quarter results, Mattel has updated its full-year guidance for 2024. While it has slightly decreased its revenue forecasts, the company increased its adjusted gross margin expectations by 125 basis points at the midpoint, indicating improved operational efficiency. Notably, the company remains committed to its guidance for Adjusted EBITDA and Adjusted EPS.

Goldman Sachs Analyst Highlights

The Goldman Sachs analyst remains optimistic about Mattel, emphasizing its strategic focus on cost management and financial stability. This positive outlook is rooted in the company's efforts to enhance balance sheet flexibility and return capital to shareholders, which positions it favorably amid ongoing economic fluctuations.

Long-Term Growth Potential

Goldman's price target of $22, based on 12.0 times the estimated earnings per share for 2026, underscores their confidence in Mattel’s future earnings potential. The firm’s support highlights confidence in the company’s strategic execution, which is critical for maintaining market competitiveness.

Operational Efficiencies and Cost Management

In recent updates, Mattel demonstrated resilience by managing to offset overall gross billings declines with gains in other segments. The company reported an adjusted EPS exceeding analyst expectations, showcasing its ability to adapt and thrive even in a tough operational climate.

Achieving Cost Savings Goals

As part of its broader strategy, Mattel has raised its annual cost savings goal to around $75 million while aiming for total cost reductions of $200 million by 2026. The updated gross margin forecast for the year is set to reach 50%, an increase from the previous projection of 48.5% to 49%.

Analyst Support Reflects Confidence

Several other financial institutions like BofA Securities, Citi, and DA Davidson have also reaffirmed their Buy ratings on Mattel. Their price targets range from $26 to $28, demonstrating widespread confidence in the company’s direction despite market headwinds.

Valuation Metrics Indicate Strong Potential

According to recent market data, Mattel's P/E ratio stands at 18.01, suggesting a fair valuation relative to its earnings. Additionally, a PEG ratio of 0.45 indicates that the stock may be undervalued concerning its future growth. Moreover, with a perfect Piotroski Score of 9, Mattel showcases strong financial reliability.

Focus on Shareholder Value

While Mattel has opted not to pay dividends, its focus on share buybacks illustrates its commitment to providing value to shareholders. The impressive EBITDA growth rate of 29.05% over the past year highlights the successful implementation of cost management and operational efficiencies, underpinning the positive forecast from Goldman Sachs.

Frequently Asked Questions

What are Goldman Sachs' projections for Mattel's stock?

Goldman Sachs anticipates a 24% upside, maintaining a price target of $22.00.

How did Mattel perform in Q3?

The company reported a revenue decline but exceeded expectations in Adjusted EBITDA and Adjusted EPS.

What changes were made to Mattel's yearly forecasts?

Mattel lowered its revenue projections but increased its adjusted gross margin expectations by 125 basis points.

What is the consensus view among analysts on Mattel?

Analysts from various institutions, including BofA and Citi, have maintained Buy ratings on Mattel.

How does Mattel manage financial stability?

Mattel focuses on cost management, share buybacks, and operational efficiencies to enhance financial health and shareholder value.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

IM Cannabis's Third Quarter Financial Jolt

Updated Category News Views 120

IM Cannabis Takes a Hit, But Seeks New Angles Diving into IM Cannabis's (NASDAQ: IMCC) latest financial splash is like reading a weathered old map of the stock market. The third quarter of 2026 wasn't kind to this little cannabis outfit. Revenues have nosedived to C$1.65 million from last year's C$5.08 million. It's not just the typical bad quarter blues; it's a solid...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 102

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Enjay Acquires New Method: A Strategic Synergy Unfolds

Updated Category News Views 98

Enjay's Bold Move into New Territory Here's a headline that doesn’t just flutter past like yesterday's news. Enjay Converters Ltd, straight from Cobourg, Ontario, has clinched a deal that looks like it might just shake things up a bit on the food packaging scene. They’ve bagged New Method Packaging LLC, another big player, but this time from the heartland of...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 104

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
Hybrid Bonding Market Shooting to $2.45 Billion by 2033

Updated Category News Views 126

Hybrid Bonding: The Future of Semiconductor Interconnects? Mark these words: Hybrid bonding isn't just another tech trend—it’s morphing into a billion-dollar juggernaut, my friend. With the latest numbers from MarketsandMarkets™, we see a potential leap from USD 0.38 billion in 2026 to a staggering USD 2.45 billion by 2033. We'll be seeing an eye-popping CAGR of...

Continue Reading
Sino Bio Speeds AI Drug Discovery with 4RISE Launch

Updated Category News Views 80

AI Meets Real-World Validation In the world of cutting-edge biotech, Sino Biological is turning heads with its latest move. If you're in the game of AI-driven drug discovery, their new 4RISE™ high-throughput wet-lab validation services could be the breakthrough you've been waiting for. Why? Well, the promise of AI is dazzling, but it all boils down to how fast you can...

Continue Reading
NVIDIA Faces Legal Turbulence: CEO's Exit Sparks Chaos

Updated Category News Views 161

Jensen Huang's Sudden Exit: A Barrage of Headlines In what feels like a blow delivered by a sledgehammer, NVIDIA is rocked by the abrupt resignation of its iconic co-founder and CEO, Jensen Huang. This isn't some quiet departure into the night. Nope, it's more like a cannonball being fired into the investor lounge, leaving a wreckage for all to navigate through. Huang's...

Continue Reading
Nonprofit and Partners Gift Homes to Veterans

Updated Category News Views 87

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

Continue Reading
BETR Investors Face Action: Nov. 20 Deadline Nears

Updated Category News Views 121

High Stakes for BETR Shareholders If you're holding shares in Better Home & Finance Holding Company, right now might feel like you're at a craps table with emptying pockets. BETR, trading under NASDAQ, has become the center of a legal hurricane, with investors eyeing the November 20th deadline to join a securities class action led by Hagens Berman. The class period in...

Continue Reading
Philip Scroggie's Legacy in Global Energy Projects

Updated Category News Views 116

A Lifetime of Energy Industry Excellence When you've been around the block in the energy sector as long as Philip D. Scroggie has, you're bound to pick up a few accolades. Recognized as an Inner Circle Lifetime Member, this guy has etched his name in the annals of global energy project management. Yeah, he's been a heavyweight in the oil, gas, and LNG industries, and he's...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting New Indoor Adventure: Albatross to Open Soon

Updated Category News Views 418

Albatross: A New Era in Indoor Entertainment Get ready for an unparalleled experience as Albatross prepares to open its doors, offering a unique blend of indoor mini putting, luxury bowling, craft cocktails, and vibrant dining options. This venue promises to redefine leisure and entertainment as we know it. Grand Opening Celebration Mark your calendars for the grand...

Continue Reading
Navigating Innovation: Key Insights from CIOs Worldwide

Updated Category News Views 179

Understanding the Evolving Role of CIOs The 2025 CIO Report, released by Logicalis, offers invaluable insights gathered from the perspectives of over 1,000 CIOs across the globe. The report highlights a significant shift in the responsibilities of CIOs, revealing that 95% of organizations are making technological investments focused on generating new revenue streams...

Continue Reading
Jake Owen Set to Light Up NASCAR All-Star Race Weekend Concert

Updated Category News Views 447

Exciting Concert Announcement for NASCAR All-Star Race Weekend As part of the thrilling NASCAR All-Star Race weekend, the multi-talented Jake Owen will take the stage on Saturday night as a centerpiece of the festivities. Presented by Raymer Oil, this special performance is eagerly anticipated by both race aficionados and country music fans alike. The event will be held...

Continue Reading
Keros Therapeutics Secures FDA Orphan Drug Designation for KER-065

Updated Category News Views 166

Keros Therapeutics Secures FDA Orphan Drug Designation Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company based in Lexington, has made significant strides in the treatment landscape for Duchenne muscular dystrophy (DMD) by announcing that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation for its promising candidate, KER-065....

Continue Reading
AM Best Upholds Credit Ratings for Partners Life Limited

Updated Category News Views 186

AM Best Today Affirms Partners Life Limited's Credit Ratings Recently, AM Best provided a significant update, affirming the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a” (Excellent) for Partners Life Limited. These ratings reflect a stable outlook for the company, underscoring its strong financial positioning in the insurance...

Continue Reading